Cosmetic compliance news
Timely MoCRA, FDA, and ingredient updates for cosmetic brands
Welcome to our hub for timely regulatory updates, practical guidance, and deep dives tailored to cosmetic brands selling in the u.s. and global markets. we translate complex rules — from MoCRA to labeling, ingredient bans to product safety reports — into clear actions you can use before launch, at scale, and when issues arise.
Latest regulatory updates
Safety Alert: US Nail Polish Remover Recall Highlights Risks of Prohibited Solvents
A recent enforcement action in the United States has led to the high-profile recall of nail polish remover products following the detection of methylene chloride and chloroform. Both substances are strictly prohibited in cosmetic formulations globally due to their significant
What are the main differences between EU and U.S. INCI list rules after MoCRA?
EU INCI rules require greater ingredient transparency, including allergens, colorants, and nanomaterials. MoCRA strengthens U.S. oversight through product listing, facility registration, and post-market controls. As a result, global cosmetic companies must manage INCI lists as part of a broader compliance
What are MoCRA requirements for cosmetic brands?
MoCRA requirements introduce mandatory U.S. regulations for cosmetics, including facility registration, product listing, safety substantiation, and adverse event reporting. They apply to both domestic and international brands, enhancing consumer safety, traceability, and regulatory accountability. Understanding and implementing these requirements is
What Is MoCRA Enforcement?
MoCRA reshapes U.S. cosmetics regulation by giving the FDA new authority and requiring mandatory compliance, including facility registration, product listing, safety substantiation, and adverse event reporting for both domestic and international brands, while enhancing consumer protection, traceability, and brand accountability.
Why read us
In-depth analysis & practical guidance
Our deep-dive posts combine regulatory expertise with cosmetics market experience. expect: clear checklists (PIF/CPSR-ready), sample label changes, adverse-event reporting workflows, and recommended responsible-person steps. Posts are written for product managers, regulatory leads, and CMOs who need concrete next steps — not abstract commentary.
